Learn More >

Ministry Status: Routine Monitoring and Engagement

Genetic Testing Advisory Committee

Members and Bios


Mark J. Poznansky, C.M., O.Ont., PhD
Dr. Poznansky is the current President and CEO of the Ontario Genomics Institute (OGI). He has held a broad range of positions in the life sciences, managing institutes, developing businesses, and government affairs. These include President and Scientific Director of Robarts Research Institute (London, ON); President and CEO of Viron Therapeutics; founding member and past chair of the Council for Health Research in Canada; and Associate Dean of Medicine for Research at the University of Alberta. Dr. Poznansky is a member of the Order of Ontario and the Order of Canada.


Peter Ainsworth, MB ChB, PhD, FRCPC
Dr. Ainsworth holds several positions at the London Health Sciences Centre; he is Director of the Molecular Diagnostic Laboratory and a consultant in Cancer Genetics. Adjunct Professor, Department of Biochemistry, Schulich School of Medicine & Dentistry, Western University; and Associate Scientist, Division of Genetics & Development, Children’s Health Research Institute (London, ON). He is a past Chair of the Advisory Committee: Molecular Genetics Program, Michener Institute (Toronto), and is currently an executive member of Ontario Regional Medical Genetic Centres.

Dr. Ainsworth´s research interests include: Detection and evaluation of mutations and gene variants of uncertain significance in inherited cancer predisposition genes.

Kym Boycott, MD, PhD, FRCPC
Dr. Kym Boycott is a Neurogeneticist at the Children’s Hospital of Eastern Ontario (CHEO); an Investigator at the CHEO Research Institute; an Associate Professor and Research Chair in Neurogenetics with the Faculty of Medicine at the University of Ottawa. She is the Lead Investigator of the Genome Canada, CIHR funded ‘Finding of Rare Disease Genes in Canada’ (FORGE Canada) project and its successor, ‘Enhanced Care for Rare Genetic Diseases in Canada’ (Care4Rare).

Her research, bridging clinical medicine to basic science, is focused in two areas; elucidating the molecular pathogenesis of rare inherited neurological diseases using next generation sequencing (NGS), and the translation of NGS to routine diagnostics and patient care.

Pranesh Chakraborty, MD, FRCPC, FCCMG
Dr. Chakraborty is a pediatrician, geneticist, and medical biochemist serving in several positions at CHEO. In addition to seeing patients, he is Executive Director at Newborn Screening Ontario (NSO); Associate Professor in the Department of Pediatrics, University of Ottawa; Medical Director for Better Outcomes Registry and Network (BORN) Ontario; and a Principal Investigator for the Canadian Inherited Metabolic Disease Research Network.

His research interests include: Development and evaluation of novel laboratory assays for diagnosis and screening of inborn errors of metabolism and other childhood diseases; Clinical and health services research on outcomes of children with inborn errors of metabolism; and basic translation research on inborn errors of mitochondrial tRNA metabolism.

Daniel Gaudet, MD, PhD
Dr. Daniel Gaudet is a lipidologist with an interest in community genetics and rare, severe, genetic lipid disorders. He is currently an associate professor of medicine at the Université de Montréal; and scientific director of the Université de Montréal´s Centre for community genetic medicine as well as of the Genome Quebec Biobank and the ECOGENE-21 clinical research and translational medicine Centre. His team has developed and transferred a low-cost multiplex test, for simultaneous carrier testing of 4 recessive diseases in the French Canadian founder population, to clinical and public health services. Dr. Gaudet has also served on numerous national and international committees which include the European Union´s Seventh Framework Programme (FP7) for Rare and Orphan Diseases, involvement in the World Health Organization’s (WHO) community genetics program, and the development of WHO Reports on Familial Hypercholesterolemia.

Ron Goeree, BA, MA
Mr. Goeree is a Health Economist who specializes in Health Technology Assessment (HTA). He spent 30 years at McMaster University, most recently as a Professor in the Department of Clinical Epidemiology and Biostatistics. He is the founding Director of the Programs for Assessment of Technology in Health (PATH) Research Institute at St Joseph´s Healthcare Hamilton. At McMaster’s Health Research and Methodology (HRM) Program, he developed an advanced decision analytic modelling course and founded the Field of Specialization for HTA. Ron has also been involved in developing and teaching several international workshops in HTA and economic modeling. He is a co-editor of the Value in Health journal, and sits on editorial boards for Medical Decision Making and the Journal of Medical Economics.

Michael Gollob, MD
Dr. Gollob is a Clinical Electrophysiologist with an undergraduate degree in molecular genetics from the University of Toronto; a recipient of the Mid-Career Scientist Award from the Heart and Stroke Foundation of Ontario; and holds peer-reviewed research funding from the Canadian Institutes for Health Research (CIHR).

His research focuses on the genetic and physiological basis of cardiac arrhythmia syndromes, including sudden death syndromes and the common arrhythmia of atrial fibrillation; causative genes for sudden death and atrial fibrillation were identified by his research laboratory.

Suzanne Kamel-Reid, PhD, DABMG, FACMG
Professor of Laboratory Medicine and Pathobiology, University of Toronto, Head, Clinical Laboratory Genetics and Director, Molecular Diagnostics, The University Health Network. Dr. Kamel-Reid’s clinical service laboratory is one of the largest cancer genetics testing laboratories in Canada and focuses on the diagnosis, prognosis and monitoring of many hematological malignancies as well as mutation testing in solid tumors. She is Co-Chair of the Cancer Care Ontario Molecular Oncology Advisory Committee, a member of the Ontario Personalized Medicine Network, and a member of the Ontario Genetics Secretariat Executive. Her research program is currently focused on further developing the concept of Precision Medicine and its utility in the clinical setting by assessing the use of new technologies to develop more comprehensive genetic tests for clinical use. She has been the recipient of peer reviewed grant funding from the NCIC, CIHR, Cancer Research Society, OICR and Leukemia Research Fund and has published over 160 papers and 270 abstracts in the field of genetics.

Fiona A. Miller, PhD
Dr. Miller is Associate Professor of Health Policy in the Institute of Health Policy, Management and Evaluation at the University of Toronto. She heads the Division of Health Policy and Ethics at the Toronto Health Economics and Technology Assessment (THETA) Collaborative, and is a member of the Joint Centre for Bioethics (JCB). Her program of research addresses health research and innovation systems and health technology policy from the perspective of health improvement, health equity and health care sustainability.

Tanya N. Nelson, PhD, FCCMG
Dr. Tanya Nelson is Head of the Division of Laboratory Genetics, at British Columbia (BC) Children’s & BC Women´s Hospitals (BCCH/BCWH), and Director of the BCCH Molecular Genetics Laboratory, which provides clinical inherited disease testing for the province. In addition, Dr. Nelson is a Clinical Professor in the Department of Pathology and Laboratory Medicine, University of BC (UBC); an Associate Member of the Department of Medical Genetics, UBC; a Clinical Investigator at the Child and Family Research Institute, BC; and is a member of a number of UBC committees including the UBC Children’s & Women’s Research Ethics Board. She is also an elected member of the Canadian College of Medical Geneticists (CCMG) Board of Directors.

Peter N. Ray, PhD, FCCMC, FACMG
Dr. Ray is a Professor of Molecular Genetics at the University of Toronto and Head of Genome Diagnostics at the Hospital for Sick Children. Dr. Ray is a scientific director of The Centre for Applied Genomics at Sickkids; an executive member of the Sickkids Centre for Genetic Medicine; and an executive member of the Ontario Genetics Secretariat. He is a Fellow of the Canadian College of Medical Geneticists and a Founding Fellow of the American College of Medical Genetics. Dr. Ray has published extensively in the areas of molecular genetics and molecular diagnosis.

François Rousseau, MD, MSc, FRCPC
Dr. François Rousseau is a medical biochemist with a subspecialty in molecular genetics. He is the FQR-S/MSSS/CHUQ Research Chair in Health Technology Assessment and Evidence Based Laboratory Medicine; a Professor in the Department of Molecular Biology, Medical Biochemistry and Pathology at the Université Laval’s Faculty of Medicine; a Researcher, Centre de recherche du CHU de Québec; and serves or has served on several national and international committees on diagnostic tests, including the Québec Health Technology Assessment Agency (INESSS). He is the Head of one of the largest Department of Laboratory Medicine in Canada (100 laboratory physicians, 530 technicians, over 15 million test results per year). He is also a Clinical Laboratory Visitor for Accreditation Canada since 2009.

As the designated principal investigator of the CIHR-funded Canadian APOGEE-Net/CanGeneTest research consortium on health services research in genetics his research focus is on transferring clinically useful and cost-effective genetic innovations to the health care system.

For More Information

Call ServiceOntario, Infoline at:
1-866-532-3161 (Toll-free)
In Toronto, (416) 314-5518
TTY 1-800-387-5559.
In Toronto, TTY 416-327-4282
Hours of operation: Monday to Friday, 8:30am - 5:00pm